弥漫性内生性桥脑胶质瘤患者来源异种移植模型开发的国际经验
该多中心研究评估了8个合作中心从患者尸检和活检组织开发弥漫性内生性桥脑胶质瘤临床前模型的国际经验,采用单因素和多因素分析确定与体外和体内PDX模型开发成功相关的关键因素。结果显示,活检标本体外培养成功率(84.2%)高于尸检标本(38.2%),DMEM转运培养基比Hibernate A更易成功,尸检来源原代培养物动物模型 engraftment 率(86.7%)高于活检来源(47.4%),肿瘤样本直接植入小鼠的 engraftment 成功率(68%)高于经培养后植入(40.7%)。
要点
- 活检标本体外培养成功率为84.2%,尸检标本为38.2%。
- DMEM转运样本比Hibernate A更易建立成功培养。
- 尸检来源培养物 engraftment 率86.7%,高于活检来源的47.4%。
核心结论
- 该多中心研究提供了关于建立弥漫性内生性桥脑胶质瘤患者来源临床前模型成功率的有价值信息,结果可进一步优化模型开发并最终辅助研究新的疗法。
研究设计与样本
- 评估8个合作中心从患者来源尸检和活检组织开发弥漫性内生性桥脑胶质瘤临床前模型的集体国际经验,采用单因素和多因素分析确定与体外和体内PDX开发成功相关的关键因素。
主要发现
- 体外培养成功建立自57%的样本(活检的84.2%和尸检的38.2%)。
- 用DMEM培养基转运的样本比用Hibernate A转运的样本更可能建立成功培养。
- 活检的体外培养成功率(84.2%)高于尸检(38.2%),且在层粘连蛋白包被板上以单层形式培养比神经球形式更成功。
- 尸检样本成功建立的原代培养物比活检建立的培养物更可能 engraft 于动物模型(86.7% vs. 47.4%)。
- 总体而言,弥漫性内生性桥脑胶质瘤样本直接植入小鼠时 engraftment 更成功(68%),而非培养后植入(40.7%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Diffuse intrinsic pontine glioma is the most aggressive form of high grade glioma in children with no effective therapies. There have been no improvements in survival in part due poor understanding of underlying biology, and lack of representative in vitro and in vivo models. Recently, it has been found feasible to use both biopsy and autopsy tumors to generate cultures and xenograft models. METHODS: To further model development, we evaluated the collective international experience from 8 collaborating centers to develop DIPG pre-clinical models from patient-derived autopsies and biopsies. Univariate and multivariate analysis was performed to determine key factors associated with the success of in vitro and in vivo PDX development. RESULTS: In vitro cultures were successfully established from 57% of samples (84.2% of biopsies and 38.2% of autopsies). Samples transferred in DMEM media were more likely to establish successful culture than those transported in Hibernate A. In vitro cultures were more successful from biopsies (84.2%) compared with autopsies (38.2%) and as monolayer on laminin-coated plates than as neurospheres. Primary cultures successfully established from autopsy samples were more likely to engraft in animal models than cultures established from biopsies (86.7% vs. 47.4%). Collectively, tumor engraftment was more successful when DIPG samples were directly implanted in mice (68%), rather than after culturing (40.7%). CONCLUSION: This multi-center study provides valuable information on the success rate of establishing patient-derived pre-clinical models of DIPG. The results can lead to further optimization of DIPG model development and ultimately assist in the investigation of new therapies for this aggressive pediatric brain tumor.
引用
- Tsoli M, Shen H, Mayoh C, et al. International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma. J Neurooncol. 2018. PMID: 30446898. doi:10.1007/s11060-018-03038-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。